To check Oneindia News on your Mobile
go to:   http://m.oneindia.in/news/
  •  

Want long eyelashes? Take Latisse

London, Jan 15: Who don't like to have an enthralling eyelashes. Mascara may soon become be a thing of the past, for scientists have created a drug that grows longer, thicker eyelashes.
US pharmaceutical firm Allergan, which also markets popular wrinkle treatment Botox, is the company behind the drug, Latisse, reports the Sun.

It uses the same formula as glaucoma drug Lumigan after scientists noticed the anti-blindness treatment boosted lashes. Trials showed that lashes became a quarter longer and twice as thick using Latisse.

The liquid, applied every night to the base of the hairs, also made them 18 per cent darker.
Latisse will be available on prescription in the US later this month, costing around 80 pounds for a full month-long course of treatment.

The drug is expected to be launched in the UK soon after, mainly through cosmetic doctors.
Cindy Ross, who took part in clinical trials, said: “People would say, 'Are you wearing false eyelashes?'

However, some doctors warned that the drug could have unwanted side effects and change users" eye-colour. Glaucoma patients using the drug often have permanently darker eyes after six months of treatment. Side effects can include temporary red eyes, itching and darker
eyelids.

However, Allergan said 65 million bottles of Lumigan had been sold with no reports of serious injury.

ANI

Coming soon: A drug that grows longer, thicker eyelashes

Washington, Mar 19 (ANI): A drug used to treat patients with glaucoma, a condition that raises the pressure inside the eye and can cause blindness, is now being marketed to make eyelashes longer, darker and thicker.US pharmaceutical firm Allergan, which also markets popular wrinkle treatment Botox, is the company behind the drug, Latisse.It uses the same formula as glaucoma drug Lumigan after scientists noticed the anti-blindness treatment boosted lashes."This is a new innovation for lashes. Latisse fulfills.....
User Comments
[ Post Comments ]
Be the first to comment on this article.
Oneindia  Oneindia Login